<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04019093</url>
  </required_header>
  <id_info>
    <org_study_id>IRB201801911-N</org_study_id>
    <secondary_id>R21AA026805</secondary_id>
    <nct_id>NCT04019093</nct_id>
  </id_info>
  <brief_title>Acute Effects of Alcohol Use on Chronic Orofacial Pain</brief_title>
  <official_title>Acute Effects of Alcohol Use on Chronic Orofacial Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Alcohol Abuse and Alcoholism (NIAAA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Self-medication of pain with alcohol is a common, yet risky, behavior among individuals with
      chronic orofacial pain. Chronic pain status may affect the degree to which alcohol use
      relieves pain, but the independent contributions of pain chronification and alcohol-related
      expectations and conditioning have not been previously studied. This project addresses this
      gap in knowledge and will inform further research and clinical/translational efforts for
      reducing risk associated with these behaviors.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 5, 2019</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>People with and without temporomandibular joint and muscle disorder (TMD) will receive an active oral dose of alcohol or placebo in a counterbalanced manner.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Pressure Pain Threshold</measure>
    <time_frame>Day 1; Day 2 (Laboratory sessions will be separated by at least 48 hours.)</time_frame>
    <description>Pressure applied at insertion of the masseter at which participant reports pain. VAS (visual analogue scale) pain intensity and unpleasantness ratings anchored from &quot;no pain at all&quot;/&quot;not at all unpleasant&quot; to &quot;most intense/unpleasant imaginable&quot; will be collected.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Pressure Pain Intensity - 4 fpsi</measure>
    <time_frame>Day 1; Day 2 (Laboratory sessions will be separated by at least 48 hours.)</time_frame>
    <description>Pain ratings associated with 6 foot pounds per square inch (fpsi) of pressure applied to the insertion of the masseter. VAS (visual analogue scale) pain intensity and unpleasantness ratings anchored from &quot;no pain at all&quot;/&quot;not at all unpleasant&quot; to &quot;most intense/unpleasant imaginable&quot; will be collected.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Pressure Pain Intensity - 5 fpsi</measure>
    <time_frame>Day 1; Day 2 (Laboratory sessions will be separated by at least 48 hours.)</time_frame>
    <description>Pain ratings associated with 7 foot pounds per square inch (fpsi) of pressure applied to the insertion of the masseter. VAS (visual analogue scale) pain intensity and unpleasantness ratings anchored from &quot;no pain at all&quot;/&quot;not at all unpleasant&quot; to &quot;most intense/unpleasant imaginable&quot; will be collected.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Pressure Pain Intensity - 6 fpsi</measure>
    <time_frame>Day 1; Day 2 (Laboratory sessions will be separated by at least 48 hours.)</time_frame>
    <description>Pain ratings associated with 8 foot pounds per square inch (fpsi) of pressure applied to the insertion of the masseter. VAS (visual analogue scale) pain intensity and unpleasantness ratings anchored from &quot;no pain at all&quot;/&quot;not at all unpleasant&quot; to &quot;most intense/unpleasant imaginable&quot; will be collected.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Perceived Relief</measure>
    <time_frame>Day 1; Day 2 (Laboratory sessions will be separated by at least 48 hours.)</time_frame>
    <description>Rating of relief from pain associated with consumption of the study beverage. VAS (visual analogue scale) assessing perceived relief anchored from &quot;No relief at all&quot; to &quot;Most profound relief imaginable&quot;.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Temporomandibular Joint Disorders</condition>
  <arm_group>
    <arm_group_label>TMD patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Individuals seeking care for temporomandibular joint and muscle disorder (TMD).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy social drinkers without TMD recruited as a comparison group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ethanol</intervention_name>
    <description>A beverage containing dose of ethanol individually determined to raise a participant's breath alcohol concentration up to approximately 0.08 g/dL.</description>
    <arm_group_label>Healthy controls</arm_group_label>
    <arm_group_label>TMD patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>A beverage that does not meaningfully increase breath alcohol concentration.</description>
    <arm_group_label>Healthy controls</arm_group_label>
    <arm_group_label>TMD patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Positive diagnosis of temporomandibular joint and muscle disorder (TMD) (TMD group
             only)

          -  Consume at least 1 drink/month over the past 6 months

        Exclusion Criteria:

          -  History of chronic pain other than TMD

          -  Current use of opioids

          -  Current major depression

          -  History of any psychotic disorder

          -  Undercontrolled hypertension or diabetes

          -  History of neurologic disease

          -  History of serious medical illness

          -  History of drug or alcohol dependence, including nicotine, or a pattern of hazardous
             alcohol use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>23 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeff Boissoneault, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeff Boissoneault, PhD</last_name>
    <phone>352-273-6147</phone>
    <email>jboissoneault@phhp.ufl.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael Robinson, PhD</last_name>
    <phone>352-273-6153</phone>
    <email>merobin@phhp.ufl.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Center for Pain Research and Behavioral Health at UF Health</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jeff Boissoneault, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>July 11, 2019</study_first_submitted>
  <study_first_submitted_qc>July 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 15, 2019</study_first_posted>
  <last_update_submitted>May 27, 2020</last_update_submitted>
  <last_update_submitted_qc>May 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>alcohol effects</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Temporomandibular Joint Disorders</mesh_term>
    <mesh_term>Temporomandibular Joint Dysfunction Syndrome</mesh_term>
    <mesh_term>Facial Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

